These findings demonstrated that T-LGL with an indolent clinical course was occasionally found, and rare types of lethal and curable EBV+/− CD8+ TCL or T-LPDs with HLH were also detected in RA patients treated with MTX and TNF inhibitors. The gene discussed is CD8A; the disease is rheumatoid arthritis.